相似文献
1
Mass Drug Administration With High-Dose Ivermectin and Dihydroartemisinin-Piperaquine for Malaria Elimination in an Area of Low Transmission With High Coverage of Malaria Control Interventions: Protocol for the MASSIV Cluster Randomized Clinical Trial.
JMIR Res Protoc. 2020 Nov 19;9(11):e20904. doi: 10.2196/20904.
2
Mass drug administration of ivermectin and dihydroartemisinin-piperaquine against malaria in settings with high coverage of standard control interventions: a cluster-randomised controlled trial in The Gambia.
Lancet Infect Dis. 2022 Apr;22(4):519-528. doi: 10.1016/S1473-3099(21)00557-0. Epub 2021 Dec 15.
3
Entomological impact of mass administration of ivermectin and dihydroartemisinin-piperaquine in The Gambia: a cluster-randomized controlled trial.
Parasit Vectors. 2022 Nov 17;15(1):435. doi: 10.1186/s13071-022-05557-4.
4
Repeat Ivermectin Mass Drug Administrations for Malaria Control II: Protocol for a Double-blind, Cluster-Randomized, Placebo-Controlled Trial for the Integrated Control of Malaria.
JMIR Res Protoc. 2023 Mar 20;12:e41197. doi: 10.2196/41197.
5
Protocol for a cluster randomised placebo-controlled trial of adjunctive ivermectin mass drug administration for malaria control on the Bijagós Archipelago of Guinea-Bissau: the MATAMAL trial.
BMJ Open. 2023 Jul 7;13(7):e072347. doi: 10.1136/bmjopen-2023-072347.
6
Risk factors for non-participation in ivermectin and dihydroartemisinin-piperaquine mass drug administration for malaria control in the MASSIV trial.
Malar J. 2024 Feb 22;23(1):54. doi: 10.1186/s12936-024-04878-2.
7
Effect of mass drug administration on malaria incidence in southeast Senegal during 2020-22: a two-arm, open-label, cluster-randomised controlled trial.
Lancet Infect Dis. 2025 Jun;25(6):656-667. doi: 10.1016/S1473-3099(24)00741-2. Epub 2025 Jan 9.
8
Adjunctive ivermectin mass drug administration for malaria control on the Bijagos Archipelago of Guinea-Bissau (MATAMAL): a quadruple-blinded, cluster-randomised, placebo-controlled trial.
Lancet Infect Dis. 2025 Apr;25(4):424-434. doi: 10.1016/S1473-3099(24)00580-2. Epub 2024 Nov 14.
9
From informed consent to adherence: factors influencing involvement in mass drug administration with ivermectin for malaria elimination in The Gambia.
Malar J. 2021 Apr 26;20(1):198. doi: 10.1186/s12936-021-03732-z.
10
The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in Southeast Asia: A cluster randomised trial.
PLoS Med. 2019 Feb 15;16(2):e1002745. doi: 10.1371/journal.pmed.1002745. eCollection 2019 Feb.
引用本文的文献
1
Asymptomatic school children and adults are important for the human infectious reservoir for Plasmodium falciparum malaria in an area of low endemicity in The Gambia.
J Infect. 2025 Jul;91(1):106507. doi: 10.1016/j.jinf.2025.106507. Epub 2025 May 20.
2
Risk factors for non-participation in ivermectin and dihydroartemisinin-piperaquine mass drug administration for malaria control in the MASSIV trial.
Malar J. 2024 Feb 22;23(1):54. doi: 10.1186/s12936-024-04878-2.
3
Entomological impact of mass administration of ivermectin and dihydroartemisinin-piperaquine in The Gambia: a cluster-randomized controlled trial.
Parasit Vectors. 2022 Nov 17;15(1):435. doi: 10.1186/s13071-022-05557-4.
4
Doing 'reciprocity work': The role of fieldworkers in a mass drug administration trial in the Gambia.
Glob Public Health. 2022 Dec;17(12):4116-4128. doi: 10.1080/17441692.2022.2125998. Epub 2022 Oct 2.
5
Serological evaluation of the effectiveness of reactive focal mass drug administration and reactive vector control to reduce malaria transmission in Zambezi Region, Namibia: Results from a secondary analysis of a cluster randomised trial.
EClinicalMedicine. 2022 Feb 14;44:101272. doi: 10.1016/j.eclinm.2022.101272. eCollection 2022 Feb.
6
Broadening the range of use cases for ivermectin - a review of the evidence.
Trans R Soc Trop Med Hyg. 2022 Mar 2;116(3):201-212. doi: 10.1093/trstmh/trab114.
7
Drug Repurposing: A Review of Old and New Antibiotics for the Treatment of Malaria: Identifying Antibiotics with a Fast Onset of Antiplasmodial Action.
Molecules. 2021 Apr 15;26(8):2304. doi: 10.3390/molecules26082304.
8
From informed consent to adherence: factors influencing involvement in mass drug administration with ivermectin for malaria elimination in The Gambia.
Malar J. 2021 Apr 26;20(1):198. doi: 10.1186/s12936-021-03732-z.
本文引用的文献
1
Optimisation and standardisation of a multiplex immunoassay of diverse antigens to assess changes in malaria transmission using sero-epidemiology.
Wellcome Open Res. 2020 Apr 23;4:26. doi: 10.12688/wellcomeopenres.14950.2. eCollection 2019.
2
A Roadmap for the Development of Ivermectin as a Complementary Malaria Vector Control Tool.
Am J Trop Med Hyg. 2020 Feb;102(2s):3-24. doi: 10.4269/ajtmh.19-0620.
3
Ivermectin as a novel complementary malaria control tool to reduce incidence and prevalence: a modelling study.
Lancet Infect Dis. 2020 Apr;20(4):498-508. doi: 10.1016/S1473-3099(19)30633-4. Epub 2020 Jan 13.
4
Safety, Pharmacokinetics, and Mosquito-Lethal Effects of Ivermectin in Combination With Dihydroartemisinin-Piperaquine and Primaquine in Healthy Adult Thai Subjects.
Clin Pharmacol Ther. 2020 May;107(5):1221-1230. doi: 10.1002/cpt.1716. Epub 2019 Dec 27.
5
Modelling the relationship between malaria prevalence as a measure of transmission and mortality across age groups.
Malar J. 2019 Jul 23;18(1):247. doi: 10.1186/s12936-019-2869-9.
6
Efficacy and risk of harms of repeat ivermectin mass drug administrations for control of malaria (RIMDAMAL): a cluster-randomised trial.
Lancet. 2019 Apr 13;393(10180):1517-1526. doi: 10.1016/S0140-6736(18)32321-3. Epub 2019 Mar 14.
7
Pharmacokinetics of ascending doses of ivermectin in Trichuris trichiura-infected children aged 2-12 years.
J Antimicrob Chemother. 2019 Jun 1;74(6):1642-1647. doi: 10.1093/jac/dkz083.
8
Pyronaridine-artesunate for treating uncomplicated Plasmodium falciparum malaria.
Cochrane Database Syst Rev. 2019 Jan 8;1(1):CD006404. doi: 10.1002/14651858.CD006404.pub3.
9
Mass Drug Administration With Dihydroartemisinin-piperaquine and Malaria Transmission Dynamics in The Gambia: A Prospective Cohort Study.
Clin Infect Dis. 2019 Jul 2;69(2):278-286. doi: 10.1093/cid/ciy870.
10
Safety and mosquitocidal efficacy of high-dose ivermectin when co-administered with dihydroartemisinin-piperaquine in Kenyan adults with uncomplicated malaria (IVERMAL): a randomised, double-blind, placebo-controlled trial.
Lancet Infect Dis. 2018 Jun;18(6):615-626. doi: 10.1016/S1473-3099(18)30163-4. Epub 2018 Mar 27.
Zotero 插件